ActRIIB Enzyme Activity Inhibitor Screening Kit Cell Biology Kits and anti-detachment slides are used

and anti-detachment slides are used

The protein encoded by this gene is a member of the Toll-like receptor (TLR) family and plays a fundamental role in pathogen recognition and activation of innate immunity

also known as MAPK3

also known as dopa decarboxylase (DDC)

ActRIIB Enzyme Activity Inhibitor Screening Kit Cell Biology Kits and anti-detachment slides are usedProduct Specification Background STX 001, the leading program of Supercede, is a novel oral small molecule Activin Receptor Type II (ACTRII) kinase inhibitor currently in preclinical development for the treatment of obesity. In Phase II clinical studies, inhibiting the ACTRII signaling pathway has been proven to significantly reduce fat while stimulating an increase in lean body mass (muscle). For patients with obesity, achieving significant fat